Navigation Links
Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer
Date:12/17/2007

owing administration of the standard dose of trastuzumab.

Of 26 patients enrolled in the trial, 20 were evaluable for efficacy (3 patients were not evaluable for efficacy and 3 patients are too early to assess). Of the 26 patients enrolled, 21 were treated with Kosan's prior Cremophor(R)-containing injection formulation of tanespimycin (4 of whom were crossed over to receive the recently introduced Injectable Suspension formulation), and 5 were treated with the Injectable Suspension formulation (3 of whom were recently enrolled and are not yet evaluable). Of the 20 patients evaluable for efficacy, 11 responded, yielding a clinical benefit rate of 55%.

-- 5 patients experienced confirmed partial responses, including,

-- 1 patient with 75% decrease in liver metastases with 42% drop in

CEA; 8 months on study;

-- 1 patient with 45% decrease in a hilar node, continuing on study

after 14 months;

-- 1 patient with 33% decrease in right breast lesions with decreased

tumor markers, continuing on study after 7 months;

-- 1 patient with 57% decrease in lymph nodes, liver and left breast

lesions, continuing on study after 7 months; and

-- 1 patient with 37% decrease in lymph nodes, continuing on study

after 5 months.

-- 2 patients experienced minor responses with decreased tumor markers (on

study for 6 and 5 months).

-- 4 patients had stable disease for 4, 4, 7, and 8 months.

Common toxicities were mainly Grade 1 and 2 and included diarrhea, fatigue, dizziness and headache. Treatment-related Grade 3 toxicities were experienced by 3 patients and included reversible fatigue and headache, increased liver function tests that resolved in 9 days and unsteady gait and euphoric mood that resolved in a single day. Noticeably absent were toxicities associated with conventional chemotherapy, including alopecia, mye
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
2. New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties
3. 3 strikes, youre out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause
4. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
5. International Survey Shows People Over Forty Ignore Risk of Blindness
6. Aidas Rh-Apo2L Clinical Testing Shows Preliminary Efficacy in Helping to Treat Lung Cancer, Stomach Cancer, Lymphoma, Pancreatic Cancer & Kidney Cancer
7. Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity
8. Video shows buckyballs form by shrink wrapping
9. National Survey Shows Most Women Are Not Satisfied With Their Progesterone Treatment
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... today that the National Institutes of Health (NIH) has awarded the company a ... by the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases. AxioMx ...
(Date:9/1/2015)... NJ (PRWEB) , ... September 01, 2015 , ... ... that highlights the opportunities for advanced analytics utilizing data lakes in the healthcare ... industries, Healthcare has seen an explosion of data over the last few years as ...
(Date:9/1/2015)... ... September 01, 2015 , ... Research ... California Los Angeles, Boston University School of Medicine, Frederick National Laboratory for Cancer ... the world’s first multidisciplinary Open Access journal. , Christopher Ryan PhD, of ...
(Date:8/31/2015)... GUELPH, ON , Aug. 31, 2015 /PRNewswire/ - BIOREM ... new orders totalling $5.7 million. The orders are for air emission ... "Of particular note is a large order for a ... our equipment will be replacing a competitor,s system that failed ... see in our engineered solutions," said Derek S. Webb ...
Breaking Biology Technology:AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3
... 2012   Spherix Incorporated (NASDAQ: SPEX ... diabetes, metabolic syndrome and atherosclerosis, and provider of technical ... pharmaceutical companies, today announced that it has entered into ... its common stock and warrants to purchase shares of ...
... Cambrex Corporation (NYSE: CBM ) announced ... on Monday, February 6, 2012 after the market closes. ... call to discuss the fourth quarter 2011 financial results.  ... Tuesday, February 7, 2012 at 8:30 a.m. Eastern Time ...
... strength of spider silk, the robust nature of the ... tears and winds that exceed hurricane strength. Now, ... with complex computer simulations has shown that web durability ... the overall web design compensates for damage and the ...
Cached Biology Technology:Spherix Announces Registered Direct Offering of $1.15 Million 2Spherix Announces Registered Direct Offering of $1.15 Million 3A spider web's strength lies in more than its silk 2A spider web's strength lies in more than its silk 3A spider web's strength lies in more than its silk 4
(Date:8/20/2015)... , Aug. 20, 2015 The ... consumers that are active and healthy. However, wearable ... the hospital environment to help improve diagnostic capabilities ... video from the Wearable Technologies Conference 2015 ... new applications for wearables in healthcare.    ...
(Date:8/18/2015)... , Aug. 17, 2015 Research ... addition of the "Global Biometric Authentication & ... - Estimation & Forecast, 2015-2020" report to ... authentication and identification systems market is expected to ... 2015 to 2020 and generate over $25 billion ...
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that four of its ... solution, have officially been named FIDO Certified™ by ... of the certification, Synaptics, Natural ID™ fingerprint solutions ... Authentication Framework (UAF) standard and are interoperable among ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3
... 26 The Peter and Patricia Gruber Foundation International Prize ... with an event to be held at Rockefeller University in ... and Neuroscience Prize recipients will be announced live at the ... Brain, and Society." The discussion will feature a panel ...
... at the way that dolphins, whales and porpoises scythe ... maximum aquatic agility. However, no one had ever analysed ... lift that they generate, the drag that they experience ... from Duke University teamed up with Mark Murray from ...
... investigators in the Vanderbilt Center for Structural Biology have ... structure of the largest membrane-spanning protein to date. , ... pictures" of small proteins, large proteins and particularly ... been reluctant to smile for the camera. , In ...
Cached Biology News:NYC science symposium marks Gruber Prize program 10th anniversary 2Dolphins get a lift from delta wing technology 2Structural biology scores with protein snapshot 2Structural biology scores with protein snapshot 3
Synonym: modified Grace's Insect medium...
Schneider's Drosophila - Insect medium...
... more than doubles the benefits of high ... analysis cycles of the standard binary system ... tandem mode. Difficult separations are dramatically improved ... heartcut configurations, on-line sample preparation is fully ...
... We can introduce random mutations to the ... be then cloned into a vector of choice ... Mutation frequency can be set to a ... Number of clones 106-108. Mutations can be ...
Biology Products: